Pay in 4 interest-free payments of $6.60 Learn more
Ships within 48 hours · Estimated delivery Oct 27 - Nov 1
Rankings update automatically as new providers are reviewed and scores change
Abdulghani AA, et al
The delivery is what is new
GIP receptor agonism, the second target, is shared with tirzepatide (Mounjaro, Zepbound)
In preclinical rodent research it is characterized as a cytoprotective and angiomodulatory agent, reported to influence the VEGFnitric-oxide signaling axis, modulate angiogenesis during muscle and tendon healing, and promote granulation-tissue and collagen formation at wound sites
US$ 20.32
US$ 25.99
US$ 25.19
